Brian Abrahams's
Stock Forecasts
10.2%
5/49 win trades
Price targets by Brian Abrahams
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Vertex Pharmaceuticals Incorporated VRTX | 9 months ago | $400 2.43% upside | $469.22 | TheFly | |
 Applied Therapeutics, Inc. APLT | 10 months ago | $4 710.04% upside | $9.42 | StreetInsider | Previous targets (0) |
 Sage Therapeutics, Inc. SAGE | 10 months ago | $4 -53.97% downside | $4.91 | StreetInsider | |
 IGM Biosciences, Inc. IGMS | 12 months ago | $17 1228.12% upside | $16.54 | TheFly | |
 Regeneron Pharmaceuticals, Inc. REGN | about 1 year ago | $1,282 123.03% upside | $1,139.41 | TheFly | |
 Neurocrine Biosciences, Inc. NBIX | about 1 year ago | $136 2.40% upside | $123.76 | TheFly | |
 Gilead Sciences, Inc. GILD | about 1 year ago | $72 -38.77% downside | $75.59 | StreetInsider | |
 Intra-Cellular Therapies, Inc. ITCI | about 1 year ago | $106 -19.61% downside | $73.63 | StreetInsider | |
 Sarepta Therapeutics, Inc. SRPT | about 1 year ago | $181 814.14% upside | $140.06 | StreetInsider | |
 Incyte Corporation INCY | about 1 year ago | $66 -22.77% downside | $65.7 | TheFly | Previous targets (0) |
 Biogen Inc. BIIB | about 1 year ago | $282 103.24% upside | $214.16 | StreetInsider | |
 CVS Health Corporation CVS | about 1 year ago | $74 4.49% upside | $58.58 | Benzinga | Previous targets (0) |
 Xenon Pharmaceuticals Inc. XENE | over 1 year ago | $55 47.21% upside | $36.25 | StreetInsider | Previous targets (0) |
 Neumora Therapeutics, Inc. Common Stock NMRA | over 1 year ago | $29 1657.46% upside | $9.71 | StreetInsider | |
 Corbus Pharmaceuticals Holdings, Inc. CRBP | over 1 year ago | $82 798.13% upside | $43.87 | StreetInsider | |
 Mind Medicine (MindMed) Inc. MNMD | over 1 year ago | $22 135.29% upside | $8.25 | StreetInsider | Previous targets (0) |
 Pliant Therapeutics, Inc. PLRX | over 1 year ago | $45 2900% upside | $13.79 | StreetInsider | Previous targets (0) |
 Contineum Therapeutics, Inc. Class A Common Stock CTNM | over 1 year ago | $30 222.58% upside | $16 | TheFly | Previous targets (0) |
Other analysts covering same stocks
Andrew Galler
Wolfe Research
100%
win rate
Geoff Porges
Leerink Partners
100%
win rate
Joseph France
Seaport Global
100%
win rate
Zhiqiang Shu
Berenberg Bank
66.67%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate